Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$363K Buy
1,482
+16
+1% +$3.44K 0.11% 49
2026
Q1
$319K Buy
1,466
+4
+0.3% +$887 0.11% 50
2025
Q4
$324K Buy
1,462
+10
+0.7% +$2.28K 0.11% 51
2025
Q3
$329K Buy
1,452
+20
+1% +$4.07K 0.12% 50
2025
Q2
$276K Buy
1,432
+17
+1% +$3.16K 0.1% 56
2025
Q1
$255K Sell
1,415
-44
-3% -$8.55K 0.1% 56
2024
Q4
$247K Sell
1,459
-1
-0.1% -$184 0.09% 61
2024
Q3
$286K Buy
1,460
+11
+0.8% +$2.05K 0.11% 53
2024
Q2
$242K Buy
1,449
+86
+6% +$14.2K 0.11% 57
2024
Q1
$220K Buy
1,363
+1
+0.1% +$172 0.1% 53
2023
Q4
$236K Buy
1,362
+1
+0.1% +$146 0.11% 52
2023
Q3
$201K Buy
+1,361
New +$200K 0.11% 50
2023
Q2
Sell
-1,461
Closed -$235K 59
2023
Q1
$235K Buy
1,461
+3
+0.2% +$459 0.12% 60
2022
Q4
$215K Buy
1,458
+12
+0.8% +$1.84K 0.1% 66
2022
Q3
$217K Buy
+1,446
New +$207K 0.11% 68

Other funds holding ABBV

Enzi Wealth's ABBV Position: Q2 2026 in Review

Enzi Wealth increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $3.44K and bringing the position to 1,482 shares worth $363K. The position accounts for 0.11% of the portfolio, ranked #49.

Enzi Wealth first reported a position in ABBV in Q3 2022 and has held it in 15 quarters since. 2,369 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Enzi Wealth held 1,482 shares of AbbVie worth $363K as of Q2 2026.
  • Enzi Wealth bought 16 AbbVie shares in Q2 2026, an estimated $3.44K.
  • AbbVie made up 0.11% of Enzi Wealth's portfolio in Q2 2026, its #49 holding.
  • Enzi Wealth first reported a position in AbbVie in Q3 2022 and has held it in 15 quarters since.
  • 2,369 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Enzi Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.